drugset / Trial / NCT01836809

Nesiritide and Renal Function After the Total Artificial Heart

NCT01836809

Phase 4 Terminated 2 enrolled Virginia Commonwealth University
RandomizedParallel-groupTriple-blindTreatment

Summary

The prevalence of renal dysfunction after implantation of the artificial heart is high. The infusion of exogenous B-type natriuretic peptide (BNP) after implantation of the total artificial heart (TAH) improves renal function in a sustained manner. The renal protective and hormone-modulating effects of nesiritide may be enhanced with ventriculectomy compared to heart failure surgery that leaves the native myocardium intact. The goal of this project is to determine the renal protective effects of nesiritide after implantation of a mechanical device.

Timeline

Start
2013-04
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nesiritide Protein / enzyme biologic 0.005 ug/kg Other